Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2002
07/11/2002WO2002053175A2 Use of botulinum toxin for treatment of articular pathologies
07/11/2002WO2002053164A1 Drynaria extractions for treating osteoporosis and their extraction process
07/11/2002WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin
07/11/2002WO2002052954A2 Nutritional composition for a bone condition
07/11/2002WO2002028480A3 Methods of therapy for b-cell malignancies
07/11/2002WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides
07/11/2002WO2002017914A8 Fused pyrrolocarbazoles against inflammation
07/11/2002WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor
07/11/2002WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof
07/11/2002WO2002008221A3 Capsaicin receptor ligands
07/11/2002WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
07/11/2002WO2001078756A3 Agent for postoperative use after the removal of bone tumours
07/11/2002WO2001046443A3 Proteases
07/11/2002WO2001045577A3 Intervertebral disc treatment devices and methods
07/11/2002WO2001034205A3 Use of lytic toxins and toxin conjugates
07/11/2002WO2001025438A3 Ifn-alpha homologues
07/11/2002WO2001021213A3 Inhibition of secretion from non-neuronal cells
07/11/2002WO2001020018A3 Diagnosing and treating arthritic disorders
07/11/2002WO2001010430A9 Use of estrogen compounds for prevention and treatment of ischemic damage
07/11/2002WO2000028982A3 Increasing bone strength with selected bisphosphonates
07/11/2002US20020091279 15R-5,6,15-trihydroxy-7,9,13-trans- 11-cis-eicosatetraenoic oracid,15R-5,14,15-trihydroxy-6,10,12-trans-8-cis-eicosatetraenoic acid, or 15-hydroxyeicosatetraenoic acid; anticarcinogenic agents
07/11/2002US20020091263 Biaryl substituted purine derivatives as potent antiproliferative agents
07/11/2002US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product
07/11/2002US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1
07/11/2002US20020091138 Treating vascular proliferative disorders
07/11/2002US20020091131 Useful particularly as remedies for bone diseases and arthritis
07/11/2002US20020091127 Semicarbazides and their uses
07/11/2002US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
07/11/2002US20020091108 Stable salts of O-acetylsalicylic acid with basic amino acids
07/11/2002US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection.
07/11/2002US20020091077 Osteogenic protein is provided alone or dispersed in a biocompatible non-rigid, amorphous carrier having no defined surfaces
07/11/2002US20020090703 Mammalian protein phosphatases
07/11/2002US20020090671 Bone stimulating factor
07/11/2002US20020090419 Food formulations with a high calcium content
07/11/2002US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
07/11/2002US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products
07/11/2002CA2433828A1 Novel estrogen receptor ligands and methods i
07/11/2002CA2433573A1 Alkanoic acid derivatives, process for their production and use thereof
07/11/2002CA2432409A1 Tropolone derivative
07/10/2002EP1221439A1 Tetrahydroquinoline derivatives
07/10/2002EP1220947A2 50 human secreted proteins
07/10/2002EP1220942A1 41 human secreted proteins
07/10/2002EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
07/10/2002EP1220920A1 The prv-1 gene and use thereof
07/10/2002EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
07/10/2002EP1220909A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
07/10/2002EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
07/10/2002EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy
07/10/2002EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
07/10/2002EP1220865A1 43 human secreted proteins
07/10/2002EP1220863A1 Purine derivatives
07/10/2002EP1220852A1 Substituted diazepans
07/10/2002EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
07/10/2002EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
07/10/2002EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
07/10/2002EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors
07/10/2002EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity
07/10/2002EP1220693A1 Formulations for delivery of osteogenic proteins
07/10/2002EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions
07/10/2002EP0973793B1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
07/10/2002EP0952975B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
07/10/2002EP0679088B1 Pulmonary delivery of active fragments of parathyroid hormone
07/10/2002CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells
07/10/2002CN1358195A Inhibitors of integrin alpha V beta 6
07/10/2002CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy
07/10/2002CN1358192A 嘌呤衍生物 Purine derivatives
07/10/2002CN1358178A Pharmaceutical compounds
07/10/2002CN1358175A Pyrimidinone compounds
07/10/2002CN1358094A Method for treating chronic pain using MEK inhibitors
07/10/2002CN1358091A Estrogen receptor-beta ligands
07/10/2002CN1357541A Phosphatidase A2 inhibitor and its prepn process and use
07/10/2002CN1357377A Chinese medicine liniment for treating cervical vertebra disease and its prepn
07/10/2002CN1357361A Shehong Gugui medicated wine
07/10/2002CN1357358A Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process
07/10/2002CN1357357A Blood circulation activating capsule for treating bone injury and its prepn process
07/10/2002CN1357356A Fracture setting granule for treating bone injury and its prepn process
07/10/2002CN1357355A Fracture setting Chinese medicine capsule for treating bone injury and its prepn process
07/10/2002CN1357346A Osteoporosis treaitng medicine comprising effective components extracted from Chinese medicinal material
07/10/2002CN1357338A Hyperosteogeny treating plaster
07/10/2002CN1357323A New application of threonic acid and its salt
07/09/2002US6417394 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators
07/09/2002US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid
07/09/2002US6417333 Modified human parathyroid hormone
07/09/2002US6417329 Purified polypeptide
07/09/2002US6417237 Macromolecular drug complexes and compositions containing the same
07/09/2002US6417227 Methods of delivery of cetyl myristoleate
07/09/2002US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof
07/09/2002US6417219 Enzyme inhibitors and osteoarthritis
07/09/2002US6417218 Substituted imidazoles, their preparation and use
07/09/2002US6417215 Calcilytic compounds
07/09/2002US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them
07/09/2002US6417188 Arylalkanoylpyridazines
07/09/2002US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
07/09/2002US6416991 Genetic engineered protein
07/09/2002US6416737 Increasing bone strength with selected bisphosphonates
07/04/2002WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level
07/04/2002WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors
07/04/2002WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
07/04/2002WO2002051836A1 Dipeptidyl peptidase iv inhibitor
07/04/2002WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives